Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05673408 · ClinicalTrials.gov registry record

NIBP Validation Study

A clinical trial of Critical Illness, sponsored by Philips Clinical & Medical Affairs Global.

Recruiting
Registry status
189
Enrollment target
5
Study locations

NCT05673408 is a study of Critical Illness that is actively recruiting participants, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 189 participants, below the 3,136-participant average among 91 other Critical Illness trials with a reported enrollment target (94% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05673408, a study of Critical Illness, is actively recruiting participants, sponsored by Philips Clinical & Medical Affairs Global.

RECRUITING
Registry status
189 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this study is to compare measurements of blood pressure (BP) between the Philips non-invasive blood pressure (NIBP) system (including NIBP cuff and portable patient monitor) and invasive radial for Subject Group 2 and 3, and radial or umbilical arterial line for neonates (A-line) in critical care patients.

Conditions Studied

Interventions

  • DEVICE Philips IntelliVue X3 Patient Monitor

Study Locations (5)

Florida

  • Mayo Clinic Jacksonville - Jacksonville

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Oregon

  • Oregon Health & Science University - Portland

Texas

  • University Health Women's and Children's Hospital - San Antonio

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 189 participants
Start Date 2023-06-23
Est. Completion 2026-12-31

What the Registry Record Tells You About NCT05673408

The ClinicalTrials.gov registry entry for NCT05673408 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 189 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,136-participant average among 91 other Critical Illness trials with a reported enrollment target (94% lower). The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Critical Illness appearing as the primary indexed condition, and to 1 intervention - of which Philips IntelliVue X3 Patient Monitor is the first listed.

NCT05673408 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Florida, North Carolina, Oregon.

Frequently Asked Questions

What is clinical trial NCT05673408 about?

NCT05673408 is a clinical study titled "NIBP Validation Study". The purpose of this study is to compare measurements of blood pressure (BP) between the Philips non-invasive blood pressure (NIBP) system (including NIBP cuff and portable patient monitor) and invasive radial for Subject Group 2 and 3, and radial or umbilical arterial line for neonates (A-line) in c...

What is the current status of trial NCT05673408?

This trial is currently recruiting. The enrollment target is 189 participants. The study started on 2023-06-23. Estimated completion is 2026-12-31.

What conditions does trial NCT05673408 study?

This clinical trial studies the following conditions: Critical Illness.

What interventions are being tested in trial NCT05673408?

The interventions under investigation include: Philips IntelliVue X3 Patient Monitor (DEVICE).

Who is sponsoring clinical trial NCT05673408?

This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05673408 being conducted?

This trial has 5 study locations across Florida, North Carolina, Oregon, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.